SCHEMBL7870261

SCHEMBL7870261

COC([C]=O)(c1ccc(Cl)cc1)c1ccc(Cl)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.40
KMT2A Q03164 5/20 0.40
CYP19A1 P11511 2/20 0.39
GRIN2D O15399 1/20 0.37
GRIN3B O60391 1/20 0.37
GRIN1 Q05586 1/20 0.37
GRIN2A Q12879 1/20 0.37
GRIN2B Q13224 1/20 0.37
GRIN2C Q14957 1/20 0.37
GRIN3A Q8TCU5 1/20 0.37
TSHR P16473 1/20 0.35
MAPK1 P28482 1/20 0.35
HIF1A Q16665 1/20 0.35
POLB P06746 1/20 0.35
MIF P14174 1/20 0.34
LMNA P02545 1/20 0.33
CYP2A6 P11509 1/20 0.33
HPGD P15428 1/20 0.33
EDNRB P24530 1/20 0.33
EDNRA P25101 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7873896 0.78 ALDH1A1 (0.46) MEN1KMT2ATSHRMAPK1HIF1A
SCHEMBL6209830 0.71 KMT2A (0.50) MEN1KMT2ACYP19A1GRIN2DGRIN3B
SCHEMBL8824095 0.70 MEN1 (0.48) MEN1KMT2ACYP19A1GRIN2DGRIN3B
SCHEMBL1817529 0.70 MEN1 (0.48) MEN1KMT2ACYP19A1GRIN2DGRIN3B
SCHEMBL17532646 0.69 MEN1 (0.52) MEN1KMT2ACYP19A1GRIN2DGRIN3B
SCHEMBL10840347 0.69 MEN1 (0.52) MEN1KMT2ACYP19A1GRIN2DGRIN3B
SCHEMBL3724084 0.68 MEN1 (0.41) MEN1KMT2ACYP19A1GRIN2DGRIN3B
SCHEMBL28588993 0.67 MEN1 (0.56) MEN1KMT2ACYP19A1GRIN2DGRIN3B
SCHEMBL31497682 0.66 MEN1 (0.62) MEN1KMT2ACYP19A1TSHRMAPK1
SCHEMBL2768675 0.66 MEN1 (0.62) MEN1KMT2ACYP19A1TSHRMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6329502-B1 VIRICIDES AGAINST HUMAN IMMUNODEFICIENCY VIRUS; TREATMENT OF AIDS (ACQUIRED IMMUNE DEFICIENCY SYNDROME) JAPAN ENERGY CORPORATION (JP) 2001-12-11 US disclosed
US-6313094-B1 COMPOSITION FOR INHIBITING HUMAN IMMUNODEFICIENCY VIRUS REPLICATION JAPAN ENERGY CORPORATION (JP) 2001-11-06 US disclosed
EP-0490667-B1 HIV protease inhibitors JAPAN ENERGY CORP (JP) 1999-06-09 EP disclosed
EP-0490667-A2 HIV protease inhibitors JAPAN ENERGY CORPORATION (JP) 1992-06-17 EP disclosed